Share this article
Share this article
EXTON, Pa., April 6, 2021 /PRNewswire/ Frontage Laboratories and Frontage Clinical Services are pleased to announce that we have developed the capability to perform full-service human Absorption, Metabolism, and Excretion (hAME) studies with radiolabeled compounds at our clinical site in Secaucus, NJ. We have obtained the full approval of the NJ Department of Environmental Protection to conduct such studies evaluating radiolabeled drug candidates in humans. Frontage Clinical Services, which has over 20 years of experience conducting early phase clinical research studies, plans to begin healthy volunteer recruitment and study conduct in Q2 2021.
The ability to execute in-life hAME studies at our 160-bed Phase 1 clinic in Secaucus, NJ complements Frontage s extensive experience in conducting radiolabeled studies, including Quantitative Whole-Body Autoradiography (QWBA)/dosimetry, mass balance, and metabolite identification/profiling.
50 years later, zoom meeting held to celebrate 1970 men s water polo silver medal! mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.